CARDIFF ONCOLOGY, INC. (CRDF) Operating income 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual operating income history from SEC filings — each fiscal year as reported.
-$49.0MFY2025 · since FY2016: -$40.1M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -0.6% |
| FY2024 | -$48.7M | -7.1% |
| FY2023 | -$45.4M | -13.8% |
| FY2022 | -$39.9M | -38.3% |
| FY2021 | -$28.9M | -51.2% |
| FY2020 | -$19.1M | -14.4% |
| FY2019 | -$16.7M | +2.2% |
| FY2018 | -$17.1M | +33.4% |
| FY2017 | -$25.6M | +36.2% |
| FY2016 | -$40.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross profitCRDF Gross marginCRDF Operating marginCRDF Operating cash flowCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total assetsCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →